Viewing Study NCT06714708

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-29 @ 3:17 PM
Study NCT ID: NCT06714708
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2024-11-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
Sponsor: Anhui Provincial Cancer Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC View
None Neoadjuvant Immunotherapy View
None Low Dose Radiotherapy View
None Sintilimab View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None Neoadjuvant Immunotherapy View
None Low Dose Radiotherapy View
None Sintilimab View